Navigation Links
Exergen Granted New Patent for Temporal Artery Thermometers
Date:3/17/2011

WATERTOWN, Mass., March 17, 2011 /PRNewswire/ -- A recently issued patent extends protection of the technology incorporated in Exergen's award winning and best selling medical thermometer brand, the TemporalScanner™ Temporal Artery Thermometers.  Exergen Corporation has recently been granted U.S. Patent No. 7,787,938, entitled, "Temporal Artery Temperature Detector" by the US Patent and Trademark Office, adding to the already extensive Exergen portfolio of valuable intellectual property rights that it has developed for its non-invasive thermometry products.

With 15 US Patents protecting the TemporalScanner professional versions, and 10 US Patents protecting the home model, Exergen continues to vigorously defend its intellectual property rights.  It has brought a number of lawsuits over the years to successfully stop companies from infringing upon Exergen's rights with regard to infrared temperature measuring products. Currently Exergen has brought suit against Kidz-Med, Inc., American Scientific Resources, Inc. and Tecnimed S.R.L for patent infringement in the United States District Court for the District of Massachusetts.

"This new patent confirms and protects important innovations in non-invasive thermometry contained in our Temporal Artery Thermometers," said Dr. Francesco Pompei, Exergen CEO and inventor of the patented technology.  "These innovations are central to the overwhelming success of the temporal artery method, which many competitors would like to use.  As a U.S. manufacturer we rely on strong patent protection to protect our rights, and do our part to help protect the spirit of innovation in a highly competitive world."

Exergen Corporation is recognized worldwide as an innovator and leading manufacturer of patented infrared thermometers, scanners, sensors and controls.  Its products are used in a wide variety of industrial and medical applications for both professionals and consumers.  Its TemporalScanner medical thermometers are responsible for nearly a billion temperatures taken per year in thousands of hospitals and clinics.  Its home model is used in more than 3 million homes and is the #1 selling retail brand. For additional information, visit www.exergen.com.


'/>"/>
SOURCE Exergen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Exergen TemporalScanner Effective in Detecting Fevers in Children Aged 1-4 Years, Study Finds
2. Exergen TemporalScanner Thermometer Best Selling Brand at Retailers
3. Exergen TemporalScanner Sponsors Game Time Temperature for NFL and College Bowl Games
4. Exergen Game Time Temperature Contest Helps Football Fans Tackle Cold and Flu Season
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
7. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
8. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
9. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
10. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
11. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... Summary This report provides all the information ... interests and activities since 2010. Description The Partnering Deals ... the partnering activity of one of the world,s leading life ... upon purchase to ensure inclusion of the most up to ... be delivered in PDF format within 1 working day of ...
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
Breaking Medicine Technology:
(Date:3/28/2017)... DC (PRWEB) , ... March 28, 2017 , ... WHO: ... Dr. Toni Bark , WHAT: , Medical doctors and PhD scientists will speak to ... written to President Trump in support of an independent vaccine safety commission. , ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... Vilnius, Lithuania (PRWEB) , ... March 28, 2017 ... ... identification technologies, today announced the release of two biometric time and attendance tracking ... Bio Attendance 4.0 software. NCheck Cloud Bio Attendance uses biometric face recognition ...
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... ... , ... A minimally invasive porcelain veneer is increasing in ... of Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive ... laboratories and technicians that create these veneers. , According to National Board ...
Breaking Medicine News(10 mins):